MedDataX Logo

Thyroid Functions in Children With Congenital Heart Diseases

NCT ID: NCT05103774

Last Updated: 2021-11-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-01

Study Completion Date

2022-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Thyroid hormone is critical for normal neurocognitive development in young infants, and even transient hypothyroidism can cause adverse neurodevelopmental outcomes. In a population of infants with CHD who already bear a high risk of long-term developmental delay, detection of hypothyroidism, even of a transient nature, may be even more consequential, and routine periodic monitoring of thyroid function may be necessary to reduce the risk of neurodevelopmental disabilities

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Value of Thyroid Functions in Children With Congenital Heart Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A: children exposed to any type of radiation or contrast

Group A: children exposed to any type of radiation or contrast

T3-T4-TSH

Intervention Type DIAGNOSTIC_TEST

thyroid function tests

Group B : children not exposed to an type of radiation or contrast

Group B : children not exposed to an type of radiation or contrast

T3-T4-TSH

Intervention Type DIAGNOSTIC_TEST

thyroid function tests

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

T3-T4-TSH

thyroid function tests

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All children since birth up to age of 12 years old including both genders diagnosed to have CHD exposed to radiation, contrast or not.

Exclusion Criteria

* above 12 years old
Minimum Eligible Age

1 Year

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hend Abdelrahim Saber

Resident doctor at Pediatric department Sohag University hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital of Sohag University

Sohag, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

hend raheem saber, master

Role: CONTACT

Phone: 01017590751

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

hend raheem saber, master

Role: primary

Eman Mohamed Fahmy, md

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh Med-21-10-24

Identifier Type: -

Identifier Source: org_study_id